Nephros Inc. (NEPH) Stock Price

NEPHStock

$3.65−31.52%52W

Market Cap$39.64M

P/E33.23x

PEG Ratio—

Div yield—

Beta1.74

NEPH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)16.83%

Price vs S&P 500 (4W)-15.25%

VGM Score64.70

P/E Ratio (Annual)33.23x

P/CF (Annual)24.12x

Book Value / Share (Quarterly)$1.10

P/TBV (Annual)5.34x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)23.48%

Cash Flow / Share (Quarterly)$-0.06

Price vs S&P 500 (YTD)-37.13%

Gross Margin (TTM)61.26%

Net Profit Margin (TTM)8.38%

EPS (TTM)$0.16

10-Day Avg Trading Volume0.06M

EPS Excl Extra (TTM)$0.16

Revenue Growth (5Y)17.03%

EPS (Annual)$0.11

ROI (Annual)11.69%

Gross Margin (Annual)61.87%

Net Profit Margin (5Y Avg)-23.67%

Cash / Share (Quarterly)$0.43

P/E Basic Excl Extra (TTM)22.85x

Revenue Growth QoQ (YoY)36.16%

P/E Normalized (Annual)33.23x

ROA (Last FY)8.75%

Revenue Growth TTM (YoY)24.20%

EBITD / Share (TTM)$0.16

ROE (5Y Avg)-34.69%

Operating Margin (TTM)7.92%

Cash Flow / Share (Annual)$0.15

P/B Ratio3.32x

P/B Ratio (Quarterly)3.24x

Net Income / Employee (Annual)$33,200

EV / Revenue (TTM)1.69x

Net Interest Coverage (TTM)-427.00x

ROA (TTM)12.30%

EPS Growth QoQ (YoY)391.78%

EV / EBITDA (TTM)19.46x

EPS Incl Extra (Annual)$0.11

Current Ratio (Annual)4.06x

Quick Ratio (Quarterly)2.63x

3-Month Avg Trading Volume0.02M

52-Week Price Return-31.52%

EV / Free Cash Flow (Annual)21.27x

P/E Incl Extra (TTM)22.85x

Revenue / Employee (TTM)$575,600

Tangible BV / Share (Quarterly)$1.06

P/S Ratio (Annual)2.11x

Asset Turnover (Annual)1.38x

52-Week High$6.42

Operating Margin (5Y Avg)-15.13%

EPS Excl Extra (Annual)$0.11

CapEx CAGR (5Y)40.63%

Tangible BV CAGR (5Y)-3.04%

26-Week Price Return26.74%

Quick Ratio (Annual)2.82x

13-Week Price Return-3.44%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)4.07x

Enterprise Value$34.99M

Revenue / Share Growth (5Y)12.69%

Asset Turnover (TTM)1.47x

Book Value / Share Growth (5Y)-5.45%

Revenue / Employee (Annual)$521,900

Inventory Turnover (Annual)2.45x

Pretax Margin (Annual)6.42%

Cash / Share (Annual)$0.51

3-Month Return Std Dev79.38%

Gross Margin (5Y Avg)56.99%

Net Income / Employee (TTM)$48,200

ROE (Last FY)11.70%

Net Interest Coverage (Annual)-95.00x

EPS Basic Excl Extra (Annual)$0.11

P/FCF (TTM)39.28x

Receivables Turnover (TTM)6.75x

EV / Free Cash Flow (TTM)21.08x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$0.16

Receivables Turnover (Annual)8.96x

ROI (TTM)16.17%

P/S Ratio (TTM)1.91x

Pretax Margin (5Y Avg)-14.82%

Revenue / Share (Annual)$1.71

Tangible BV / Share (Annual)$0.91

Forward P/E18.40x

Price vs S&P 500 (52W)-47.05%

P/E Ratio (TTM)22.85x

EPS Growth TTM (YoY)26.13%

Year-to-Date Return-25.20%

5-Day Price Return2.24%

EPS Normalized (Annual)$0.11

ROA (5Y Avg)-18.85%

Net Profit Margin (Annual)6.35%

Month-to-Date Return-1.62%

Cash Flow / Share (TTM)$-0.14

EBITD / Share (Annual)$0.12

Operating Margin (Annual)6.10%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)24.35x

ROI (5Y Avg)-34.10%

P/E Excl Extra (TTM)22.85x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.16

P/TBV (Quarterly)3.37x

P/B Ratio (Annual)5.08x

Inventory Turnover (TTM)2.37x

Pretax Margin (TTM)8.45%

Book Value / Share (Annual)$0.96

Price vs S&P 500 (13W)-6.12%

Beta1.74x

P/FCF (Annual)24.12x

Revenue / Share (TTM)$1.86

ROE (TTM)16.20%

52-Week Low$2.66

vGradeC

gGradeB

mGradeB

vgmGradeB

NEPH Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.01	$0.05	+443.00%(+$0.04)
Q1 2026	May 7, 2026	$0.01	$0.01	+0.00%(+$0.00)
Q4 2025	Mar 12, 2026	$0.01	$0.01	+0.00%(+$0.00)
Q3 2025	Nov 6, 2025	-$0.02	$0.03	+250.00%(+$0.05)
Q2 2025	Aug 7, 2025	-$0.03	$0.02	+180.00%(+$0.05)

NEPH Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.13

4.00

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NEPHNephros Inc.	C	B	B	1.9x	17.0%	61.3%	7.9%	$3.65
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Nephros Inc.

Nephros Inc is a commercial-stage company developing high-performance water solutions for medical and commercial markets. The medical segment focuses on water filtration, pathogen detection, and next-generation hemodiafiltration systems for renal disease patients, while the commercial segment manufactures water filters that improve taste and reduce odor, biofilm, and equipment fouling. Revenue is primarily generated through product sales.

NEPH Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.03

Revenue estimate$5.49M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

MYOMyomo Inc.Orthopedic & Prosthetic Devices
POCIPrecision Optics Corporation, Inc. Common StockElectromedical Equipment
MBAIMBody AI Ltd. Ordinary ShareX-Ray Equipment
SYPRSypris Solutions IncIndustrial Instruments
MINDMIND Technology, Inc. Common Stock (DE)Defense Systems & Equipment
RPIDRapid Micro Biosystems, Inc. Class A Common StockLab Analytical Instruments
PRPOPrecipio, Inc. Common StockLab Analytical Instruments
HBIOHarvard Bioscience IncLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.0

Buy

Consensus rating

52-Week Range

Low$2.66

High$6.42